Niox Share Discussion Threads

[earwacks] 11/5/2023 09:03

Last year as Circassia we got a 4 month update at the AGM on May 12th, ahead of expectations naturally. The share price was around 35p then dipped below 30p for a couple of weeks and then continued trading between 34 to 40p range. Since then we have seen the name change and capital reduction so my feeling is 50p is not overly expensive for the updates and expectations this year especially in light of China's market opening up and of course the possibility of the launch of a home kit at some stage. This year Niox AGM is scheduled for May 18th, which hopefully will include news on first 4 months trading this year GL all

[mginvestor] 05/5/2023 13:59

Looks like a cup and handle pattern to my untrained eye



GLAH

[bc4] 05/5/2023 09:20

The real spread for 50,000 shares is 48.90 to sell 49.70 to buy so well above the quoted price to sell

[p1nkfish] 04/5/2023 17:19

Looks about ready for a run.

[saadia110] 04/5/2023 16:21

Seller may be clearing, close to breaking 50p.

[thedudie] 04/5/2023 12:50

50p to buy.... :)

[apad] 04/5/2023 11:57

OK found it
"Once FeNO testing and NIOX® are established as normal practice in Primary Care the Company plans to explore a home use product, so that asthma patients can perform a FeNO test at home and help improve their asthma outcomes."
apad

[apad] 04/5/2023 11:55

Missed "home-testing".
Reference?
apad

[earwacks] 04/5/2023 11:50

Good point dudie. News on home tasting kits will be the game changer. This is what will make it a razor blade stock.with those and volume of trades going through either people are taking a gamble now or news is leaking. Can’t see why there would be such a large seller at this stage of proceedings but obviously the shares have to be coming from somewhere.

[thedudie] 03/5/2023 16:46

There is normally a trading statement at the AGM (18th May this year). If trading has continued to improve I would think the high 50s would be in reach at least. More so if there is other news about home testing or anything else.

[saadia110] 03/5/2023 16:22

There must be a big seller unwinding their position so the share price struggles to move forward. Once the seller has cleared it will break 50p.

[earwacks] 03/5/2023 15:27

And now for something completely different a buy at 2.30 of 700000 shares and after several days relentless buying the share price moves up 2p. Whooppee.

[earwacks] 27/4/2023 15:27

Takes some buying to move this stock up. doing my bit still!

[bc4] 24/4/2023 20:21

Trading update due middle of May hopefully more good news

[earwacks] 24/4/2023 18:47

All the hall marks of a bid coming. Seems to be takeover season. Wonder who wants it apart from Astra. Absolute cash cow. 977,000 shares traded?That accounts for two trades, what about all the others

[p1nkfish] 28/3/2023 16:27

Hope it's not 4 yrs or so to get back to 70p.
No covid in the way this time and company in a better state overall.
How long before Dir's get their goodies and we get 55p-70p?

[p1nkfish] 28/3/2023 16:22

30 consecutive days, I won't complain when it gets there.

"33 percent of the Options will vest in the event that a Vesting Level of 55p is attained, 66 percent of the Options will vest in the event that a Vesting Level of 62.5p is attained, with 100 per cent. vesting in the event that a Vesting Level of 70p is attained."

Oct 2018 was last time at 70p approx.
Dec 2018 for 55p, approx.

[chrysalis99] 28/3/2023 16:17

Greed greed greed. As if they weren't well enough remunerated already. And RNS released after 4pm due to the shame of it all.

[masurenguy] 21/3/2023 08:23

Singer Capital Markets issued a broker note this morning increasing its shareprice target to 56p.

[thedudie] 21/3/2023 07:46

A great set of numbers given that there was a continuing Covid impact.
So after a 15% revenue increase in 2022 it looks like 2023 has started brightly with revenues up 19% for the first 2 months....

Good progress!

[masurenguy] 21/3/2023 07:11

PRELIMINARY RESULTS FOR THE YEARED 31 DECEMBER 2022

21 March 2023: NIOX Group today announces unaudited results for the year ended 31 December 2022.

Financial highlights

-- Underlying revenue growth of 15% to £31.3 million (2021: £27.9 million) excluding a one-off revenue item of £0.6 million in China

-- Profit before tax £2.4 million, excluding the benefit of the Beyond Air consideration of £8.1 million (2021: loss of £2.1 million)

-- Group adjusted EBITDA(2) at £7.3 million, ahead of upgraded consensus estimates (2021: £0.6 million in a transitional year)

-- Net cash £19.4 million (31 December 2021: £12.6 million)

2022 was a good year for the Group. The results demonstrate the clear ability of our business model to generate profitable growth, and double digit sales growth at historical trend levels was achieved despite ongoing adverse effects of Covid-19 in several of our major markets. The business has made a positive start to 2023 and the Board expects another year of solid progress, notwithstanding the somewhat mixed macroeconomic outlook.

Ian Johnson, NIOX's Executive Chairman, said: "2022 was a significant year for the Group with the business substantially right-sized and the implementation of a distributor-led sales strategy well underway. These initiatives gave rise to a much-reduced cost base and generated scalable revenue growth. The Group remains debt free and has significant cash resources to continue implementing its business strategy of accessing and promoting the benefits of its products to healthcare professionals in primary and secondary care, who diagnose and treat the large population of patients suffering from asthma. Significant progress was made in 2022 to sell NIOX(R) FeNO devices into primary care, and I am pleased to report that this is continuing into 2023.

The business has proved very resilient during both the Pandemic and the more recent global macroeconomic conditions. The high level of recurring revenues provides good visibility of earnings and together with high gross margins are delivering profitable growth. The Group has made a positive start to 2023 with revenues up 19% in the first two months of the year on the equivalent period in 2022. The Board believes that the strong business model will drive further top line growth and continue to deliver improved shareholder value going forward."

[edwardt] 18/3/2023 12:46

I guess a buyback is coming??

[masurenguy] 15/3/2023 16:33

Very encouraging to see a small rise into the close on a big down day in the market.

[earwacks] 09/3/2023 12:31

The market is quite illiquid . Cant get a quote on some quite decent stock I hold. Not that I want to sell. However no problem to sell quite sizeable holding in one go on Niox. Fortunately hit the right button to decline! If it was an overhang they have quite a few to sell. Market makers probably pretty pleased to bag 7 million at 45p if thats what happened. If that had been dumped on the open market would be back to 40p or less I would have thought

[bc4] 09/3/2023 12:10

Well 50p did not hold hopefully another go soon